Cheng Wang, PhD

Massachusetts General Hospital

Academic Titles

Associate Professor, Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Research Program Affiliation

Member, Gynecologic Cancers

Member, Cancer Cell Biology

Research Abstract

Globally, approximately 860,000 women were expected to be diagnosed with ovarian or cervical cancer in 2018, with an estimated 490,000 associated deaths worldwide. These stunning numbers are attributed, in part, to the fact that the etiology for ovarian and cervical cancer are not entirely clear. Research in my laboratory mainly focuses on identifying the signaling pathways and molecules that contribute to the physiological and pathological changes in the female reproductive tract (mainly ovarian and cervical tissues), aiming to provide new strategies for effective early diagnosis and better treatment of these lethal gynecological malignancies.